Crystal clear: A landmark pharma patent victory in Japan

Journal of Intellectual Property Law and Practice

Volumn 3, Issue 7, 2008, Pages 473-478

  Tessensohn, John A ^a   Yamamoto, Shusaku ^a  

^a Shusaku Yamamoto   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896276061     PISSN: None     EISSN: 17471540     Source Type: Journal    
DOI: 10.1093/jiplp/jpn086     Document Type: Review

References (24)

1. 'The bitterest pill' Economist 62, 26 January 2008.
2. M Sato, 'Drug sector faces major realignment', Nikkei Weekly, 3 March 2008.
3. US Commercial Service, Pharmaceuticals-Japan, Department of Commerce, Government of the United States of America, http://www.buyusa.gov/asianow/jpharmaceuticals.html.
4. C Fujioka, 'In Japan, seniors with an edge', Int'l Herald Trib., 1 January 2007.
5. F Nukaga, Minister of Finance, Fiscal Policy Speech at the 169th Session of the National Diet, 18 January 2008, http://www.mof.go.jp/english/budget/e20080118.htm.
6. O Saigusa, 'Japan's healthcare system and pharmaceutical industry' (2006) 4 Journal of Generic Medicines 23-29.
7. Y Matsuzaki, 'Generic drug makers seize chance', Nikkei Weekly, 7 February 2007.
8. Astellas Pharma. Inc. v Taiyo Yakuhin Co. Ltd, Heisei 17 (wa) 19162, 13 March 2007, Tokyo District Court.
9. Taiyo Yakuhin Co. Ltd, v Astellas Pharma. Inc., Heisei 19 (ne) 10034, 10 September 2007.
10. Whitehead et al., 'Managing generic competition and patent strategies in the pharmaceutical industry' 2008 3(4) Journal of Intellectual Property Law & Practice 226-235.
11. R Hilfiker, Polymorphism: In the Pharmaceutical Industry (2006) xv.
12. J Bernstein, Polymorphism in Molecular Crystals (2002) 240-241.
13. D Braga, Making Crystals by Design: Methods, Techniques and Applications (2007) 307-309.
14. Glaxo Inc. v Novopharm Ltd, 42 USPQ2d 1257 (Fed. Cir. 1997).
15. Pfizer Canada v Ranbaxy 2007 FC 898 (Fed. Ct. 2007).
16. Novartis Corp. v Ben Venue Laboratories, Inc., 60 USPQ2d 1836 (Fed. Cir. 2001).
17. Zenith Laboratories, Inc. v Bristol-Myers Squibb Co., 30 USPQ2d 1285 (Fed. Cir. 1994).
18. S Ekins and B Wang, Computer Applications in Pharmaceutical Research and Development (2006) 18-20.
19. Abbott v Ranbaxy & Ors. [2004] EWHC 2723.
20. Ministry of Finance of Japan, Current Japanese Fiscal Conditions and Issues to be Considered (2007) 27.
21. J McCurry, 'Japan moves to guard against future health-spending rises', (29 April 2006) 367(9520) Lancet 1385-1386.
22. 'Health Ministry to push generic drugs in prescriptions' Nikkei, 11 November 2007.
23. 'MARKET SHARE: generic drugs' Nihon Keizai Shimbun, 12 November 2007.
24. Astellas Pharma Inc., Annual Report 2007 (2007) 11.